IL33 and neoplasm: Similarly, immunization with CurDCs plus IL-33 significantly slowed MPC-11 tumor growth as compared to CurDC immunization (Figure 4B), whereas IL-33 had marginal effects on BMDC-induced antitumor efficacy (Figure 4B).